The North American ophthalmic lasers market is expected to grow at a CAGR of 6.2% during the forecast period and expected to reach $437.0 million in 2025 from $287.4 million in 2018. The combination of significant accuracy and safety make lasers highly useful ophthalmic tools. However, the lasers require to be used accurately and safely during the procedure to prevent hazards and accidental exposure to laser beams. Hence, highly skilled professionals are required who can effectively operate a laser device. The major factors that are encouraging the adoption of ophthalmic lasers include increasing prevalence of glaucoma and cataract, technological innovations in ophthalmic laser technology and significant growth in the geriatric population base.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/north-american-ophthalmic-lasers-market
The North American ophthalmic lasers market is segmented on the basis of type, application, and end-user. Based on the type, the market is further classified into SLT laser, Nd: YAG laser, excimer laser, femtosecond laser, cyclodiode laser, and others. There are multiple applications for Nd: YAG lasers and is most commonly used for the treatment of posterior capsular opacification after cataract surgery. Other applications comprise the treatment of recurrent vitreous floaters and corneal erosions. Additionally, based on application, the market is further classified into cataract surgery, refractive surgery, AMD, cornea transplant surgery, glaucoma surgery, diabetic retinopathy, and others. Based on end-user, the market is further classified into hospital, clinic and ambulatory surgical center.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/north-american-ophthalmic-lasers-market
The major companies in the market include Carl Zeiss Meditec AG, Johnson & Johnson Service, Inc., NIDEK Co., Ltd., and Ziemer Ophthalmic Systems AG. Some key strategies adopted by these companies include merger and acquisitions, product launches and partnerships to attract a large number of customer base and expand share in the market. For instance, in November 2017, the company announced the launch of the VYZULTA solution which helps in the reduction of intraocular pressure in patients with open-angle glaucoma and ocular hypertension. In the same year, the company introduced, LUMIFY an over-the-eye eyedrop for ocular redness in the eyes.
Market Segmentation
North American Ophthalmic Lasers Market by Type
- Excimer Laser
- Femtosecond Laser
- Cyclodiode Laser
- Nd: YAG Laser
- Selective-Laser-Trabeculoplasty (SLT) Laser
- Others
North American Ophthalmic Lasers Market by Application
- Cataract Surgery
- Glaucoma Surgery
- Diabetic Retinopathy
- Refractive Surgery
- Age-Related Macular Degeneration (AMD)
- Cornea Transplant Surgery
- Others
North American Ophthalmic Lasers Market by End-User
- Hospital
- Clinic
- Ambulatory Surgical Center
REGIONAL ANALYSIS
- United States
- Canada
COMPANY PROFILES
- Bausch & Lomb, Inc.
- Boston Scientific Corp.
- Carl Zeiss Meditec AG
- Coherent, Inc.
- IPG Photonics Corp.
- IRIDEX Corp.
- Johnson & Johnson, Service Inc.
- LIGHTMED Corp.
- LightScalpel
- NIDEK Co., Ltd.
- NoIR Laser Company, LLC.
- Novartis International AG
- Quantel Medical
- Topcon Medical Systems, Inc.
- Ziemer Ophthalmic Systems AG
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
